Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
70.74
+0.36 (0.51%)
At close: Oct 29, 2024, 4:00 PM
71.49
+0.75 (1.06%)
After-hours: Oct 29, 2024, 5:10 PM EDT

Company Description

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.

This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids.

The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications.

The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014.

Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Bio-Techne Corporation
Bio-Techne logo
Country United States
Founded 1976
IPO Date Feb 9, 1989
Industry Biotechnology
Sector Healthcare
Employees 3,050
CEO Kim Kelderman

Contact Details

Address:
614 McKinley Place N.E.
Minneapolis, Minnesota 55413
United States
Phone 612 379 8854
Website bio-techne.com

Stock Details

Ticker Symbol TECH
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000842023
CUSIP Number 09073M104
ISIN Number US09073M1045
Employer ID 41-1427402
SIC Code 2836

Key Executives

Name Position
Kim Kelderman Chief Executive Officer, President and Director
James T. Hippel Executive Vice President of Finance and Chief Financial Officer
Shane Bohnen Senior Vice President, General Counsel, Corporate Secretary and Chief Sustainability Officer
William A. Geist President of Protein Sciences Segment
Dr. Matthew F. McManus M.D., MBA, Ph.D. President of Diagnostics and Genomics
Dr. Gary J. Latham Ph.D. Vice President and Chief Technology Officer
David Clair Senior Director of Investor Relations and Corporate Development
Gerry Andros Vice President of Sales and Marketing
Martin Wirtz Senior Vice President of Strategy and Corporate Development
Cheryl Bethune Senior Vice President and Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Oct 21, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 12, 2024 ARS Filing
Sep 12, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 12, 2024 DEF 14A Other definitive proxy statements
Aug 22, 2024 10-K Annual Report
Aug 8, 2024 144 Filing
Aug 7, 2024 8-K Current Report
May 31, 2024 SD Form - SD
May 14, 2024 144 Filing
May 6, 2024 10-Q Quarterly Report